The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam

Clinical trial NCT01221727 · COMPLETED

Trial details

NCT number: NCT01221727
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2010-11-01
Primary completion: 2011-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.